These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27076305)

  • 61. Analysis of the Salivary Gland Transcriptome of Unfed and Partially Fed
    Esteves E; Maruyama SR; Kawahara R; Fujita A; Martins LA; Righi AA; Costa FB; Palmisano G; Labruna MB; Sá-Nunes A; Ribeiro JMC; Fogaça AC
    Front Cell Infect Microbiol; 2017; 7():476. PubMed ID: 29209593
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oral Vaccination With a Formulation Combining
    Contreras M; Kasaija PD; Merino O; de la Cruz-Hernandez NI; Gortazar C; de la Fuente J
    Front Cell Infect Microbiol; 2019; 9():45. PubMed ID: 30881925
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A ten-year review of commercial vaccine performance for control of tick infestations on cattle.
    de la Fuente J; Almazán C; Canales M; Pérez de la Lastra JM; Kocan KM; Willadsen P
    Anim Health Res Rev; 2007 Jun; 8(1):23-8. PubMed ID: 17692140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of ferritin 2 for the control of tick infestations.
    Hajdusek O; Almazán C; Loosova G; Villar M; Canales M; Grubhoffer L; Kopacek P; de la Fuente J
    Vaccine; 2010 Apr; 28(17):2993-8. PubMed ID: 20171306
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Conservation and immunogenicity of the mosquito ortholog of the tick-protective antigen, subolesin.
    Canales M; Naranjo V; Almazán C; Molina R; Tsuruta SA; Szabó MP; Manzano-Roman R; Pérez de la Lastra JM; Kocan KM; Jiménez MI; Lucientes J; Villar M; de la Fuente J
    Parasitol Res; 2009 Jul; 105(1):97-111. PubMed ID: 19229557
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tick iron and heme metabolism - New target for an anti-tick intervention.
    Hajdusek O; Sima R; Perner J; Loosova G; Harcubova A; Kopacek P
    Ticks Tick Borne Dis; 2016 Jun; 7(4):565-72. PubMed ID: 26810909
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiple legumain isoenzymes in ticks.
    Hartmann D; Šíma R; Konvičková J; Perner J; Kopáček P; Sojka D
    Int J Parasitol; 2018 Feb; 48(2):167-178. PubMed ID: 29113783
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccines Against Vector-Borne Diseases.
    Kitsou C; Pal U
    Methods Mol Biol; 2022; 2411():269-286. PubMed ID: 34816411
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recent Advances in Tick Antigen Discovery and Anti-Tick Vaccine Development.
    Abbas MN; Jmel MA; Mekki I; Dijkgraaf I; Kotsyfakis M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902400
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    Cabezas-Cruz A; Espinosa PJ; Obregón DA; Alberdi P; de la Fuente J
    Front Cell Infect Microbiol; 2017; 7():375. PubMed ID: 28861402
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of Ixophilin, a thrombin inhibitor from the gut of Ixodes scapularis.
    Narasimhan S; Perez O; Mootien S; DePonte K; Koski RA; Fikrig E; Ledizet M
    PLoS One; 2013; 8(7):e68012. PubMed ID: 23874485
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Issues in tick vaccine development: identification and characterization of potential candidate vaccine antigens.
    Mulenga A; Sugimoto C; Onuma M
    Microbes Infect; 2000 Sep; 2(11):1353-61. PubMed ID: 11018452
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Developing Anti-tick Vaccines.
    Rodríguez-Mallon A
    Methods Mol Biol; 2016; 1404():243-259. PubMed ID: 27076303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current status and future prospects of multi-antigen tick vaccine.
    Parthasarathi BC; Kumar B; Ghosh S
    J Vector Borne Dis; 2021; 58(3):183-192. PubMed ID: 35170454
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dual action ectoparasite vaccine targeting 'exposed' and 'concealed' antigens.
    Trimnell AR; Hails RS; Nuttall PA
    Vaccine; 2002 Oct; 20(29-30):3560-8. PubMed ID: 12297402
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Function-guided selection of midgut antigens from Ornithodoros erraticus ticks and an evaluation of their protective efficacy in rabbits.
    Pérez-Sánchez R; Manzano-Román R; Obolo-Mvoulouga P; Oleaga A
    Vet Parasitol; 2019 Aug; 272():1-12. PubMed ID: 31395198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A combination of antibodies against Bm86 and Subolesin inhibits engorgement of Rhipicephalus australis (formerly Rhipicephalus microplus) larvae in vitro.
    Trentelman JJA; Teunissen H; Kleuskens JAGM; van de Crommert J; de la Fuente J; Hovius JWR; Schetters TPM
    Parasit Vectors; 2019 Jul; 12(1):362. PubMed ID: 31345265
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Upcoming and future strategies of tick control: a review.
    Ghosh S; Azhahianambi P; Yadav MP
    J Vector Borne Dis; 2007 Jun; 44(2):79-89. PubMed ID: 17722860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Defining the role of subolesin in tick cell culture by use of RNA interference.
    Blouin EF; Manzano-Roman R; de la Fuente J; Kocan KM
    Ann N Y Acad Sci; 2008 Dec; 1149():41-4. PubMed ID: 19120170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.